These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27419382)

  • 21. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
    Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
    J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association.
    Turrini O; Paye F; Bachellier P; Sauvanet A; Sa Cunha A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    Eur J Surg Oncol; 2013 Feb; 39(2):171-8. PubMed ID: 22999411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
    Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
    Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
    Khan M; Ashraf MI; Syed AA; Hanif F
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
    Lim JE; Chien MW; Earle CC
    Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer.
    Bergquist JR; Ivanics T; Shubert CR; Habermann EB; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB; Truty MJ
    Ann Surg Oncol; 2017 Jun; 24(6):1731-1738. PubMed ID: 28070725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries.
    Miura JT; Evans DB; Pappas SG; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2013 Dec; 20(13):4338-47. PubMed ID: 24002538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma.
    Ielpo B; Caruso R; Duran H; Diaz E; Fabra I; Malavé L; Ferri V; Alvarez R; Cubillo A; Plaza C; Lazzaro S; Kalivaci D; Quijano Y; Vicente E
    Surg Oncol; 2017 Dec; 26(4):402-410. PubMed ID: 29113659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy is associated with improved survival in patients with left-sided pancreatic adenocarcinoma.
    Ocuin LM; Hardacre JM; Ammori JB; Rothermel LD; Mohamed A; Selfridge JE; Bajor D; Winter JM
    J Surg Oncol; 2020 Dec; 122(8):1595-1603. PubMed ID: 32844445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.